Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_3
1
50%
Ph phase_1
1
50%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
Phase 3Large-scale testing
1(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Terminated(1)
Other(1)

Detailed Status

unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 11 (50.0%)
Phase 31 (50.0%)

Trials by Status

unknown150%
withdrawn150%

Recent Activity

0 active trials
Showing 2 of 2
withdrawnphase_3

Clinical Trial to Evaluate the Efficacy and Safety of DP-R212

NCT02955368
unknownphase_1

DP-R212 Pharmacokinetic Study Phase I

NCT02814500

Clinical Trials (2)

Showing 2 of 2 trials
NCT02955368Phase 3

Clinical Trial to Evaluate the Efficacy and Safety of DP-R212

Withdrawn
NCT02814500Phase 1

DP-R212 Pharmacokinetic Study Phase I

Unknown

All 2 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
2